Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Amgevita (20mg/0.4mL) |
| Active Ingredient: | Adalimumab 50mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Amgen New Zealand Limited |
| Manufacturer: | Amgen Manufacturing Limited, Juncos, Puerto Rico |
| Product: | Amgevita (40mg/0.8mL) |
| Active Ingredient: | Adalimumab 50mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Amgen New Zealand Limited |
| Manufacturer: | Amgen Manufacturing Limited, Juncos, Puerto Rico |
| Product: | Amgevita (40mg/0.8mL) Pen |
| Active Ingredient: | Adalimumab 50mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Amgen New Zealand Limited |
| Manufacturer: | Amgen Manufacturing Limited, Juncos, Puerto Rico |
| Product: | Avagard Antiseptic CHG Hand Rub |
| Active Ingredients: | Chlorhexidine gluconate 0.5%w/v Ethanol 70%v/v |
| Dosage Form: | Antiseptic solution |
| New Zealand Sponsor: | 3M New Zealand Limited |
| Manufacturer: | Pax Australia Pty Limited, Sydney, Australia |
Dated this 2nd day of September 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).